Yedi Herdiana

Dr. Yedi Herdiana

Padjadjaran University, Bandung, Jawa Barat, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2021 in Heliyon
Verified
Journal Article
Open access
YHYedi Herdiana
Yedi Herdiana
NWNasrul Wathoni
Nasrul Wathoni
SSShaharum Shamsuddin
Shaharum Shamsuddin
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi
Recently, multifunctional drug delivery systems (DDSs) have been designed to provide a comprehensive approach with multiple functionalities, including diagnostic imaging, targeted drug delivery, and controlled drug release. Chitosan-based drug nanoparticles (CSNPs) systems are employed as diagnostic imaging and delivering the drug to particular targeted sites in a regulated manner. Drug release is an important factor in ensuring high reproducibility, stability, quality control of CSNPs, and scientific-based for developing CSNPs. Several factors influence drug release from CSNPs, including composition, composition ratio, ingredient interactions, and preparation methods. Early, CSNPs were used for improving drug solubility, stability, pharmacokinetics, and pharmacotherapeutics properties. Chitosan has been developed toward a multifunctional drug delivery system by exploring positively charged properties and modifiable functional groups. Various modifications to the polymer backbone, charge, or functional groups will undoubtedly affect the drug release from CSNPs. The drug release from CSNPs has a significant influence on its therapeutic actions. Our review's objective was to summarize and discuss the relationship between the modification in CSNPs as multifunctional delivery systems and drug release properties and kinetics of the drug release model. Kinetic models help describe the release rate, leading to increased efficiency, accuracy, the safety of the dose, optimizing the drug delivery device's design, evaluating the drug release rate, and improvement of patient compatibility. In conclusion, almost all CSNPs showed bi-phasic release, initial burst release drug in a particular time followed controlled manner release in achieving the expected release, stimuli external can be applied. CSNPs are a promising technique for multifunctional drug delivery systems.

28 May 2022 in OpenNano
Verified
Journal Article
Open access
YHYedi Herdiana
Yedi Herdiana
NWNasrul Wathoni
Nasrul Wathoni
SSShaharum Shamsuddin
Shaharum Shamsuddin
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi

24 May 2021 in Polymers
Verified
Journal Article
Open access
PDF file
YHYedi Herdiana
Yedi Herdiana
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
SSSHAHARUM SHAMSUDDIN
SHAHARUM SHAMSUDDIN
IJI Made Joni
I Made Joni
Muchtaridi MuchtaridiMuchtaridi Muchtaridi
Muchtaridi Muchtaridi
Breast cancer remains one of the world’s most dangerous diseases because of the difficulty of finding cost-effective and specific targets for effective and efficient treatment methods. The biodegradability and biocompatibility properties of chitosan-based nanoparticles (ChNPs) have good prospects for targeted drug delivery systems. ChNPs can transfer various antitumor drugs to targeted sites via passive and active targeting pathways. The modification of ChNPs has attracted the researcher to the loading of drugs to targeted cancer cells. The objective of our review was to summarize and discuss the modification in ChNPs in delivering anticancer drugs against breast cancer cells from published papers recorded in Scopus, PubMed, and Google Scholar. In order to improve cellular uptake, drug accumulation, cytotoxicity, and selectivity, we examined different kinds of modification of ChNPs. Notably, these forms of ChNPs use the characteristics of the enhanced permeability and retention (EPR) effect as a proper parameter and different biological ligands, such as proteins, peptides, monoclonal antibodies, and small particles. In addition, as a targeted delivery system, ChNPs provided and significantly improved the delivery of drugs into specific breast cancer cells (MDA-MB-231, 4T1 cells, SK-BR-3, MCF-7, T47D). In conclusion, a promising technique is presented for increasing the efficacy, selectivity, and effectiveness of candidate drug carriers in the treatment of breast cancer.

1 October 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YHYedi Herdiana
Yedi Herdiana
Although nanoparticles (NPs) show tremendous potential in the laboratory, most of them fail to reach clinical applications, highlighting a significant “translational gap” in nanomedicine. This gap is often due to a lack of focus on advanced formulation strategies required to transform NPs into functional drug products. Therefore, this review systematically addresses the crucial role of secondary delivery systems in bridging this gap. We analyze and compare various advanced formulation platforms, such as sterile injectables for the intravenous route, hydrogels for topical delivery, microspheres for the oral route, dry powder formulations for inhalation, and polymer implants for controlled release, and discuss how each system addresses specific clinical challenges related to route of administration, stability, and bioavailability. We conclude that shifting the focus from nanoparticle design alone to integrated formulation strategies is a fundamental step towards accelerating the translation of nanomedicines from the laboratory to the patient.

6 August 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YHYedi Herdiana
Yedi Herdiana
EFEllin Febrina
Ellin Febrina
SNSiti Nurhasanah
Siti Nurhasanah
DGDolih Gozali
Dolih Gozali
KEKhaled M. Elamin
Khaled M. Elamin
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
Chitosan nanoparticles (CSNPs) are promising vehicles for targeted and controlled drug release. Recognized for their biodegradability, biocompatibility, low toxicity, and ease of production, CSNPs represent an effective approach to drug delivery. Encapsulating drugs within nanoparticles (NPs) provides numerous benefits compared to free drugs, such as increased bioavailability, minimized toxic side effects, improved delivery, and the incorporation of additional features like controlled release, imaging agents, targeted delivery, and combination therapies with multiple drugs. Keys parameters in nanomedicines are drug loading content and drug loading efficiency. Most current NP systems struggle with low drug loading, presenting a significant challenge to the field. This review summarizes recent research on developing CSNPs with high drug loading capacity, focusing on various synthesis strategies. It examines CSNP systems using different materials and drugs, providing details on their synthesis methods, drug loadings, encapsulation efficiencies, release profiles, stability, and applications in drug delivery. Additionally, the review discusses factors affecting drug loading, providing valuable guidelines for future CSNPs’ development.

1 May 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Nasrul WathoniNasrul Wathoni
Nasrul Wathoni
YHYedi Herdiana
Yedi Herdiana
CSCecep Suhandi
Cecep Suhandi
AMAhmed Fouad Abdelwahab Mohammed
Ahmed Fouad Abdelwahab Mohammed
AEAli El-Rayyes
Ali El-Rayyes
ANAngga Cipta Narsa
Angga Cipta Narsa
Nanoparticle systems integrating alginate and chitosan emerge as a promising avenue to tackle challenges in leveraging the potency of pharmacological active agents. Owing to their intrinsic properties as polysaccharides, alginate and chitosan, exhibit remarkable biocompatibility, rendering them conducive to bodily integration. By downsizing drug particles to the nano-scale, the system enhances drug solubility in aqueous environments by augmenting surface area. Additionally, the system orchestrates extended drug release kinetics, aligning well with the exigencies of chronic drug release requisite for antibacterial therapeutics. A thorough scrutiny of existing literature underscores a wealth of evidence supporting the utilization of the alginate-chitosan nanoparticle system for antibacterial agent delivery. Literature reviews present abundant evidence of the utilization of nanoparticle systems based on a combination of alginate and chitosan for antibacterial agent delivery. Various experiments demonstrate enhanced antibacterial efficacy, including an increase in the inhibitory zone diameter, improvement in the minimum inhibitory concentration, and an enhancement in the bacterial reduction rate. This enhancement in efficacy occurs due to mechanisms involving increased solubility resulting from particle size reduction, prolonged release effects, and enhanced selectivity towards bacterial cell walls, stemming from ionic interactions between positively charged particles and teichoic acid on bacterial cell walls. However, clinical studies remain limited, and there are currently no marketed antibacterial drugs utilizing this system. Hence, expediting clinical efficacy validation is crucial to maximize its benefits promptly.